Enovix (ENVX) Projected to Post Earnings on Wednesday

Enovix (NASDAQ:ENVX) is expected to post its Q1 2026 results after the market closes on Wednesday, April 29th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $6.9520 million for the quarter. Investors can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Wednesday, April 29, 2026 at 5:00 PM ET.

Enovix Price Performance

Enovix stock opened at $6.61 on Monday. The stock has a market capitalization of $1.44 billion, a P/E ratio of -8.58 and a beta of 2.16. Enovix has a 12-month low of $4.61 and a 12-month high of $16.49. The company has a debt-to-equity ratio of 1.90, a current ratio of 8.34 and a quick ratio of 8.13. The firm’s 50-day moving average is $5.59 and its two-hundred day moving average is $7.57.

Analyst Ratings Changes

Several equities analysts recently issued reports on ENVX shares. Oppenheimer reissued an “outperform” rating on shares of Enovix in a research note on Thursday, February 26th. Craig Hallum lowered their target price on shares of Enovix from $16.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. TD Cowen cut their price target on Enovix from $15.00 to $7.50 and set a “hold” rating for the company in a report on Thursday, February 26th. B. Riley Financial reduced their price target on Enovix from $17.00 to $10.00 and set a “buy” rating on the stock in a research note on Monday, March 2nd. Finally, Bank of America assumed coverage on Enovix in a report on Thursday, March 12th. They set a “neutral” rating and a $6.00 price objective on the stock. Six analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $13.46.

Institutional Investors Weigh In On Enovix

A number of institutional investors have recently bought and sold shares of ENVX. Parallel Advisors LLC increased its position in Enovix by 51.9% during the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after purchasing an additional 1,342 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new position in shares of Enovix in the 3rd quarter valued at $80,000. Mercer Global Advisors Inc. ADV purchased a new stake in shares of Enovix during the 3rd quarter valued at $100,000. Mackenzie Financial Corp acquired a new stake in shares of Enovix during the 4th quarter worth $77,000. Finally, CIBC Asset Management Inc acquired a new stake in shares of Enovix during the 4th quarter worth $78,000. 50.92% of the stock is currently owned by hedge funds and other institutional investors.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.